Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition

Karen A. Matthews, Laura L. Schott, Joyce Bromberger, Jill Cyranowski, Susan A. Everson-Rose, Mary Fran Sowers

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

OBJECTIVE: To test whether depressive symptoms are related to inflammatory and hemostatic markers in women approaching menopause. METHODS: A total of 3292 women enrolled in the Study of Women's Health Across the Nation (SWAN) were followed for five years and had measures of Center for Epidemiologic Studies-Depression and high sensitivity C-reactive protein, Factor VIIc, fibrinogen, plasminogen activator inhibitor Type 1(PAI-1), and tissue-type plasminogen activator antigen (tPA-ag) up to four times during the follow-up period. Women were pre- or early perimenopausal status at study entry and were of Caucasian, African American, Hispanic, Japanese, or Chinese race/ethnicity. RESULTS: Unadjusted longitudinal mixed regression models showed that over a 5-year period, higher depressive symptoms were related to higher fibrinogen, PAI-1, and tPA-ag levels, all p < .0001. Taking into account health history, medication use, ethnicity, aging, and menopausal status, the depressive symptoms were related to fibrinogen, p < .01, and PAI-1, p < .05. Depressive symptoms were related only to fibrinogen in models that also included body mass index, p < .05. CONCLUSIONS: Depressive symptoms may be associated with cardiovascular risk in perimenopausal women in part through hypercoagulability. This is the first study to test the association of depressive symptoms and hemostatic and inflammatory markers across time.

Original languageEnglish (US)
Pages (from-to)124-130
Number of pages7
JournalPsychosomatic Medicine
Volume69
Issue number2
DOIs
StatePublished - Jan 1 2007

Fingerprint

Hemostatics
Depression
Fibrinogen
Plasminogen Activator Inhibitor 1
Antigens
Plasminogen Inactivators
Thrombophilia
Women's Health
Tissue Plasminogen Activator
Menopause
Hispanic Americans
African Americans
C-Reactive Protein
Epidemiologic Studies
Body Mass Index
Health

Keywords

  • Depression
  • Hemostatis
  • Inflammation
  • Longitudinal
  • Menopause
  • Women

Cite this

Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. / Matthews, Karen A.; Schott, Laura L.; Bromberger, Joyce; Cyranowski, Jill; Everson-Rose, Susan A.; Sowers, Mary Fran.

In: Psychosomatic Medicine, Vol. 69, No. 2, 01.01.2007, p. 124-130.

Research output: Contribution to journalArticle

Matthews, Karen A. ; Schott, Laura L. ; Bromberger, Joyce ; Cyranowski, Jill ; Everson-Rose, Susan A. ; Sowers, Mary Fran. / Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. In: Psychosomatic Medicine. 2007 ; Vol. 69, No. 2. pp. 124-130.
@article{19c1bc6277394f77a54ec8294c2258b2,
title = "Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition",
abstract = "OBJECTIVE: To test whether depressive symptoms are related to inflammatory and hemostatic markers in women approaching menopause. METHODS: A total of 3292 women enrolled in the Study of Women's Health Across the Nation (SWAN) were followed for five years and had measures of Center for Epidemiologic Studies-Depression and high sensitivity C-reactive protein, Factor VIIc, fibrinogen, plasminogen activator inhibitor Type 1(PAI-1), and tissue-type plasminogen activator antigen (tPA-ag) up to four times during the follow-up period. Women were pre- or early perimenopausal status at study entry and were of Caucasian, African American, Hispanic, Japanese, or Chinese race/ethnicity. RESULTS: Unadjusted longitudinal mixed regression models showed that over a 5-year period, higher depressive symptoms were related to higher fibrinogen, PAI-1, and tPA-ag levels, all p < .0001. Taking into account health history, medication use, ethnicity, aging, and menopausal status, the depressive symptoms were related to fibrinogen, p < .01, and PAI-1, p < .05. Depressive symptoms were related only to fibrinogen in models that also included body mass index, p < .05. CONCLUSIONS: Depressive symptoms may be associated with cardiovascular risk in perimenopausal women in part through hypercoagulability. This is the first study to test the association of depressive symptoms and hemostatic and inflammatory markers across time.",
keywords = "Depression, Hemostatis, Inflammation, Longitudinal, Menopause, Women",
author = "Matthews, {Karen A.} and Schott, {Laura L.} and Joyce Bromberger and Jill Cyranowski and Everson-Rose, {Susan A.} and Sowers, {Mary Fran}",
year = "2007",
month = "1",
day = "1",
doi = "10.1097/01.psy.0000256574.30389.1b",
language = "English (US)",
volume = "69",
pages = "124--130",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition

AU - Matthews, Karen A.

AU - Schott, Laura L.

AU - Bromberger, Joyce

AU - Cyranowski, Jill

AU - Everson-Rose, Susan A.

AU - Sowers, Mary Fran

PY - 2007/1/1

Y1 - 2007/1/1

N2 - OBJECTIVE: To test whether depressive symptoms are related to inflammatory and hemostatic markers in women approaching menopause. METHODS: A total of 3292 women enrolled in the Study of Women's Health Across the Nation (SWAN) were followed for five years and had measures of Center for Epidemiologic Studies-Depression and high sensitivity C-reactive protein, Factor VIIc, fibrinogen, plasminogen activator inhibitor Type 1(PAI-1), and tissue-type plasminogen activator antigen (tPA-ag) up to four times during the follow-up period. Women were pre- or early perimenopausal status at study entry and were of Caucasian, African American, Hispanic, Japanese, or Chinese race/ethnicity. RESULTS: Unadjusted longitudinal mixed regression models showed that over a 5-year period, higher depressive symptoms were related to higher fibrinogen, PAI-1, and tPA-ag levels, all p < .0001. Taking into account health history, medication use, ethnicity, aging, and menopausal status, the depressive symptoms were related to fibrinogen, p < .01, and PAI-1, p < .05. Depressive symptoms were related only to fibrinogen in models that also included body mass index, p < .05. CONCLUSIONS: Depressive symptoms may be associated with cardiovascular risk in perimenopausal women in part through hypercoagulability. This is the first study to test the association of depressive symptoms and hemostatic and inflammatory markers across time.

AB - OBJECTIVE: To test whether depressive symptoms are related to inflammatory and hemostatic markers in women approaching menopause. METHODS: A total of 3292 women enrolled in the Study of Women's Health Across the Nation (SWAN) were followed for five years and had measures of Center for Epidemiologic Studies-Depression and high sensitivity C-reactive protein, Factor VIIc, fibrinogen, plasminogen activator inhibitor Type 1(PAI-1), and tissue-type plasminogen activator antigen (tPA-ag) up to four times during the follow-up period. Women were pre- or early perimenopausal status at study entry and were of Caucasian, African American, Hispanic, Japanese, or Chinese race/ethnicity. RESULTS: Unadjusted longitudinal mixed regression models showed that over a 5-year period, higher depressive symptoms were related to higher fibrinogen, PAI-1, and tPA-ag levels, all p < .0001. Taking into account health history, medication use, ethnicity, aging, and menopausal status, the depressive symptoms were related to fibrinogen, p < .01, and PAI-1, p < .05. Depressive symptoms were related only to fibrinogen in models that also included body mass index, p < .05. CONCLUSIONS: Depressive symptoms may be associated with cardiovascular risk in perimenopausal women in part through hypercoagulability. This is the first study to test the association of depressive symptoms and hemostatic and inflammatory markers across time.

KW - Depression

KW - Hemostatis

KW - Inflammation

KW - Longitudinal

KW - Menopause

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=33847717881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847717881&partnerID=8YFLogxK

U2 - 10.1097/01.psy.0000256574.30389.1b

DO - 10.1097/01.psy.0000256574.30389.1b

M3 - Article

VL - 69

SP - 124

EP - 130

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 2

ER -